CHENGDU, China, Sept. 22, 2022 /PRNewswire/ Keymed Biosciences (HKEX:02162) announced that the Center for Drug Evaluation (CDE) of the China National Medical Products Administration (NMPA)
INDIANAPOLIS (dpa-AFX) - The National Medical Products Administration (NMPA) of China has approved the supplemental New Drug Application or sNDA for TYVYT (sintilimab injection) in combination